Suppr超能文献

尿液中六氢大麻酚代谢物的鉴定。

Identification of human hexahydrocannabinol metabolites in urine.

机构信息

Forensic Toxicology and Chemistry, Institute of Forensic Medicine, University of Bern, Bern, Switzerland.

Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Bern, Switzerland.

出版信息

Eur J Mass Spectrom (Chichester). 2023 Oct;29(5-6):326-337. doi: 10.1177/14690667231200139. Epub 2023 Sep 14.

Abstract

Hexahydrocannabinol (HHC) is a cannabinoid that has been known since 1940 but has only recently found its way into recreational use as a psychoactive drug. HHC has been used as a legal alternative to tetrahydrocannabinol (THC) in many countries, but first countries already placed it under their narcotic substances law. Our aim was to evaluate a reliable analytical method for the proof of HHC consumption by LC-MS/MS and GC-MS. We identified the two epimers of HHC and metabolites after HHC consumption by two volunteers (inhalation by use of a vaporizer and oral intake). LC-HR-MS/MS, LC-MS/MS and GC-MS with literature data (EI-MS spectra of derivatives) and reference compounds - as far as commercially available - were used for metabolite identification. Phase-II-metabolites (glucuronides) of HHC and OH-HHC were found in urine samples with LC-HR-MS/MS and LC-MS/MS. The main metabolite was tentatively identified with GC-MS as 4'OH-HHC (stereochemistry on C9 and C4' unknown). Another major side-chain hydroxylated metabolite found by LC-MS/MS could not be unambiguously identified. Both epimers of 11-OH-HHC were found in considerable amounts in urine. (8, 9)-8-OH-HHC was identified as a minor metabolite with GC-MS and LC-MS/MS. While (9)-HHC was found in urine after oral intake and inhalation of HHC, the more psychoactive epimer (9)-HHC was only found in urine after inhalation. Several other minor metabolites were detected but not structurally identified. We found that after oral or inhalative consumption the urinary main metabolites of a diastereomeric mixture of HHC are different from the respective, major Δ-THC metabolites (11-OH-Δ-THC and 11-nor-9-carboxy-Δ-THC). Although a sensitive LC-MS/MS and GC-SIM-MS method were set-up for the reference compounds (9)-11-nor-9-carboxy-HHC and (9)-11-nor-9-carboxy-HHC, these oxidation products were not detected in urine with these techniques. To further increase sensitivity, a GC-MS/MS method was developed, and the 11-nor-9-carboxy metabolites of HHC were confirmed to be present as minor metabolites.

摘要

六氢大麻酚(HHC)是一种自 1940 年以来就为人所知的大麻素,但直到最近才作为一种精神活性药物被用于娱乐用途。在许多国家,HHC 被用作四氢大麻酚(THC)的合法替代品,但首先是一些国家已经将其纳入其麻醉物质法。我们的目的是评估一种可靠的分析方法,用于通过 LC-MS/MS 和 GC-MS 证明 HHC 的消耗。我们通过两名志愿者(通过使用蒸发器吸入和口服摄入)鉴定了 HHC 消耗后的两种差向异构体和代谢物。使用 LC-HR-MS/MS、LC-MS/MS 和 GC-MS 以及文献数据(衍生物的 EI-MS 光谱)和参考化合物(只要商业上可用)用于代谢物鉴定。在尿液样本中,使用 LC-HR-MS/MS 和 LC-MS/MS 检测到 HHC 和 OH-HHC 的 II 期代谢物(葡糖醛酸苷)。使用 GC-MS 作为主要代谢物,初步鉴定为 4'OH-HHC(C9 和 C4'立体化学未知)。另一种通过 LC-MS/MS 发现的主要侧链羟基化代谢物无法明确鉴定。在尿液中发现了相当数量的两种差向异构体 11-OH-HHC。使用 GC-MS 和 LC-MS/MS 鉴定(8,9)-8-OH-HHC 为次要代谢物。(9)-HHC 仅在吸入 HHC 后在尿液中发现,而在口服摄入和吸入 HHC 后在尿液中发现(9)-HHC。还检测到了其他几种次要代谢物,但未进行结构鉴定。我们发现,口服或吸入消耗后,HHC 立体异构体混合物的主要尿液代谢物与各自的主要 Δ-THC 代谢物(11-OH-Δ-THC 和 11-去甲-9-羧基-Δ-THC)不同。尽管建立了用于参考化合物(9)-11-去甲-9-羧基-HHC 和(9)-11-去甲-9-羧基-HHC 的敏感 LC-MS/MS 和 GC-SIM-MS 方法,但这些氧化产物未在尿液中通过这些技术检测到。为了进一步提高灵敏度,开发了一种 GC-MS/MS 方法,并确认 HHC 的 11-去甲-9-羧基代谢物作为次要代谢物存在。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验